Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea

ClinicalTrials.gov ID: NCT00196391

Public ClinicalTrials.gov record NCT00196391. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Study to Evaluate Induction of Withdrawal Bleeding After Administration of DR-2021 in Women With Secondary Amenorrhea

Study identification

NCT ID
NCT00196391
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Duramed Research
Industry
Enrollment
180 participants

Conditions and interventions

Conditions

Interventions

  • DR-2021a Drug
  • DR-2021b Drug
  • DR-2021c Drug
  • DR-2021d Drug
  • DR-2021e Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2005
Primary completion
Mar 31, 2007
Completion
Mar 31, 2007
Last update posted
Jul 29, 2014

2005 – 2007

United States locations

U.S. sites
27
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Duramed Investigational Site Mobile Alabama 36608
Duramed Investigational Site Phoenix Arizona 85032
Duramed Investigational Site Tucson Arizona 85712
Duramed Investigational Site Carmichael California 95608
Duramed Investigational Site San Diego California 92123
Duramed Investigational Site San Diego California 92130
Duramed Investigational Site Colorado Springs Colorado 80909
Duramed Investigational Site Pueblo Colorado 81001
Duramed Investigational Site Gainesville Florida 32605
Duramed Investigational Site Leesburg Florida 34748
Duramed Investigational Site Miami Florida 33143
Duramed Investigational Site Atlanta Georgia 30328
Duramed Investigational Ste Dawsonville Georgia 30534
Duramed Investigational Site Douglasville Georgia 30134
Duramed Investigational Site Laurel Maryland 20707
Duramed Investigational Site St Louis Missouri 63110
Duramed Investigational Site Alliance Nebraska 69301
Duramed Investigational Site Lawrenceville New Jersey 08648
Duramed Investigational Site Medford Oregon 97505
Duramed Investigational Site Pittsburgh Pennsylvania 15206
Duramed Investigational Site Willow Grove Pennsylvania 19090
Duramed Investigational Site Columbia South Carolina 29201
Duramed Investigational Site Memphis Tennessee 38120
Duramed Investigational Site Dallas Texas 75390
Duramed Investigational Site Houston Texas 77030
Duramed Investigational Site Houston Texas 77074
Duramed Investigational Site Newport News Virginia 23602

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00196391, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2014 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00196391 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →